IDEXX Laboratories, Inc. (IDXX)
| Market Cap | 31.76B |
| Revenue (ttm) | 3.31B |
| Net Income (ttm) | 663.95M |
| Shares Out | 83.25M |
| EPS (ttm) | 7.73 |
| PE Ratio | 49.35 |
| Forward PE | 45.45 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 409,080 |
| Open | 387.90 |
| Previous Close | 390.85 |
| Day's Range | 370.96 - 389.64 |
| 52-Week Range | 318.50 - 695.18 |
| Beta | 1.14 |
| Analysts | Buy |
| Price Target | 516.27 (+35.3%) |
| Earnings Date | Aug 2, 2022 |
About IDXX
IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinar... [Read more...]
Financial Performance
In 2021, IDXX's revenue was $3.22 billion, an increase of 18.79% compared to the previous year's $2.71 billion. Earnings were $744.85 million, an increase of 28.03%.
Financial StatementsAnalyst Forecast
According to 18 analysts, the average rating for IDXX stock is "Buy." The 12-month stock price forecast is 516.27, which is an increase of 35.34% from the latest price.
News
3 No-Brainer Stocks to Buy in a Correction
Designed to thrive in challenging economic conditions, these companies are great buys during a downturn.
IDEXX (IDXX) Q2 Earnings Surpass Estimates, 2022 View Down
IDEXX's (IDXX) Q2 top-line benefits from strong sales at the CAG and Water businesses.
Idexx Laboratories (IDXX) Surpasses Q2 Earnings Estimates
Idexx (IDXX) delivered earnings and revenue surprises of 1.30% and 0.43%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
IDEXX Laboratories Announces Second Quarter Results
Achieves second quarter revenue growth of 4% reported and 6.5% organic, driven by CAG Diagnostics recurring revenue growth of 4% reported and 7% organic, building on high prior year growth Solid demand ...
OCPNY or IDXX: Which Is the Better Value Stock Right Now?
OCPNY vs. IDXX: Which Stock Is the Better Value Option?
3 MedTech Stocks That are Likely to Beat This Earnings Season
MedTech companies' results are likely to reflect base business recovery on a year-over-year basis. Let's see how STE, TMO and IDXX are poised ahead of their earnings releases.
Idexx Laboratories (IDXX) Expected to Beat Earnings Estimates: Should You Buy?
Idexx (IDXX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Can Idexx (IDXX) Keep the Earnings Surprise Streak Alive?
Idexx (IDXX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
IDEXX Laboratories to Release 2022 Second Quarter Financial Results
WESTBROOK, Maine , July 8, 2022 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2022 second quarter results for Tu...
The 3 Best Pet Stocks to Buy Now
Pets are a big part of the family in America and that trend is only growing. Here are some top pet stocks to help you profit from the trend.
IDEXX Empowers Veterinarians with New Testing Insights that Support Earlier Diagnosis and Intervention for Preventive...
IDEXX Reference Laboratories Will Add Fecal Dx Antigen Testing with Flea Tapeworm Detection, Testing for the FGF-23 Kidney Biomarker, and Next-Day PCR Direct Testing Service WESTBROOK, Maine , June 21,...
Why Is Idexx (IDXX) Up 0.3% Since Last Earnings Report?
Idexx (IDXX) reported earnings 30 days ago. What's next for the stock?
IDEXX's (IDXX) Soft LPD Sales, Margin Pressure Concern
Distributor purchasing dynamics have an impact on IDEXX's (IDXX) CAG segment product sales.
IDEXX Laboratories to Present at Stifel Conference and Announces 2022 Investor Day
WESTBROOK, Maine , May 18, 2022 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, will part...
IDEXX (IDXX) Q1 Earnings Surpass Estimates, Margins Down
Strong sales at the CAG and Water businesses drove IDEXX's (IDXX) first-quarter 2022 revenues.
Idexx Laboratories (IDXX) Q1 Earnings Beat Estimates
Idexx (IDXX) delivered earnings and revenue surprises of 0.89% and 0.57%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
IDEXX Laboratories Announces First Quarter Results
Achieves first quarter revenue growth of 8% reported and organic, driven by CAG Diagnostics recurring revenue growth of 8% reported and 9% organic, building on high prior year growth Continued strong se...
MedTech Stocks' Q1 Earnings Due on May 4: CRL, IDXX & NUVA
MedTech companies' results are likely to reflect a rebound in the base business. Let's see how CRL, IDXX and NUVA fare this time.
Earnings Preview: Idexx Laboratories (IDXX) Q1 Earnings Expected to Decline
Idexx (IDXX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
According To Analysts, These 12 Fast-Rising Stocks Are On The Way Up
A dozen S&P 500 stocks are up strongly from the market's low this year, including consumer discretionary firms Pool and D.R. Horton plus communications services company Dish Network.
Wall Street Thinks This Stock Has 50% Upside
That prediction might be too conservative.
IDEXX (IDXX) CAG Sales Gain Traction, FX Headwind Persists
IDEXX (IDXX) has been witnessing continued high CAG Diagnostics recurring revenue growth across major regions with solid gains across its key in-clinic platforms.
IDEXX Laboratories to Release 2022 First Quarter Financial Results
WESTBROOK, Maine , April 11, 2022 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, has sch...